Compile Data Set for Download or QSAR
Report error Found 773 Enz. Inhib. hit(s) with all data for entry = 7059
TargetComplement factor D(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 50400274BDBM50400274(CHEMBL2180765 | US9085555, 373)
Affinity DataIC50: 1nMpH: 7.5 T: 2°CAssay Description:Recombinant human factor D (expressed in E. coli and purified using standard methods) at 10 nM concentration is incubated with test compound at vario...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetComplement factor D(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 50400273BDBM50400273(CHEMBL2180764 | US9085555, 375)
Affinity DataIC50: 2nMpH: 7.5 T: 2°CAssay Description:Recombinant human factor D (expressed in E. coli and purified using standard methods) at 10 nM concentration is incubated with test compound at vario...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetComplement factor D(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 170943BDBM170943(US9085555, 371)
Affinity DataIC50: 3nMpH: 7.5 T: 2°CAssay Description:Recombinant human factor D (expressed in E. coli and purified using standard methods) at 10 nM concentration is incubated with test compound at vario...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetComplement factor D(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 171262BDBM171262(US9085555, 692)
Affinity DataIC50: 3nMpH: 7.5 T: 2°CAssay Description:Recombinant human factor D (expressed in E. coli and purified using standard methods) at 10 nM concentration is incubated with test compound at vario...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetComplement factor D(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 170890BDBM170890(US9085555, 318)
Affinity DataIC50: 3nMpH: 7.5 T: 2°CAssay Description:Recombinant human factor D (expressed in E. coli and purified using standard methods) at 10 nM concentration is incubated with test compound at vario...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetComplement factor D(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 171305BDBM171305(US9085555, 735)
Affinity DataIC50: 3nMpH: 7.5 T: 2°CAssay Description:Recombinant human factor D (expressed in E. coli and purified using standard methods) at 10 nM concentration is incubated with test compound at vario...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetComplement factor D(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 50400275BDBM50400275(CHEMBL2180766 | US9085555, 127)
Affinity DataIC50: 3nMpH: 7.5 T: 2°CAssay Description:Recombinant human factor D (expressed in E. coli and purified using standard methods) at 10 nM concentration is incubated with test compound at vario...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetComplement factor D(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 171267BDBM171267(US9085555, 697)
Affinity DataIC50: 3nMpH: 7.5 T: 2°CAssay Description:Recombinant human factor D (expressed in E. coli and purified using standard methods) at 10 nM concentration is incubated with test compound at vario...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetComplement factor D(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 170864BDBM170864(US9085555, 292)
Affinity DataIC50: 3nMpH: 7.5 T: 2°CAssay Description:Recombinant human factor D (expressed in E. coli and purified using standard methods) at 10 nM concentration is incubated with test compound at vario...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetComplement factor D(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 171311BDBM171311(US9085555, 757 | US9085555, 741)
Affinity DataIC50: 3nMpH: 7.5 T: 2°CAssay Description:Recombinant human factor D (expressed in E. coli and purified using standard methods) at 10 nM concentration is incubated with test compound at vario...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetComplement factor D(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 170738BDBM170738(US9085555, 166)
Affinity DataIC50: 3nMpH: 7.5 T: 2°CAssay Description:Recombinant human factor D (expressed in E. coli and purified using standard methods) at 10 nM concentration is incubated with test compound at vario...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetComplement factor D(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 170945BDBM170945(US9085555, 374)
Affinity DataIC50: 3nMpH: 7.5 T: 2°CAssay Description:Recombinant human factor D (expressed in E. coli and purified using standard methods) at 10 nM concentration is incubated with test compound at vario...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetComplement factor D(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 170701BDBM170701(US9085555, 129)
Affinity DataIC50: 4nMpH: 7.5 T: 2°CAssay Description:Recombinant human factor D (expressed in E. coli and purified using standard methods) at 10 nM concentration is incubated with test compound at vario...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetComplement factor D(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 170878BDBM170878(US9085555, 306)
Affinity DataIC50: 4nMpH: 7.5 T: 2°CAssay Description:Recombinant human factor D (expressed in E. coli and purified using standard methods) at 10 nM concentration is incubated with test compound at vario...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetComplement factor D(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 170872BDBM170872(US9085555, 300)
Affinity DataIC50: 4nMpH: 7.5 T: 2°CAssay Description:Recombinant human factor D (expressed in E. coli and purified using standard methods) at 10 nM concentration is incubated with test compound at vario...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetComplement factor D(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 171319BDBM171319(US9085555, 749)
Affinity DataIC50: 4nMpH: 7.5 T: 2°CAssay Description:Recombinant human factor D (expressed in E. coli and purified using standard methods) at 10 nM concentration is incubated with test compound at vario...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetComplement factor D(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 171304BDBM171304(US9085555, 734)
Affinity DataIC50: 4nMpH: 7.5 T: 2°CAssay Description:Recombinant human factor D (expressed in E. coli and purified using standard methods) at 10 nM concentration is incubated with test compound at vario...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetComplement factor D(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 170953BDBM170953(US9085555, 383)
Affinity DataIC50: 4nMpH: 7.5 T: 2°CAssay Description:Recombinant human factor D (expressed in E. coli and purified using standard methods) at 10 nM concentration is incubated with test compound at vario...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetComplement factor D(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 171318BDBM171318(US9085555, 748)
Affinity DataIC50: 4nMpH: 7.5 T: 2°CAssay Description:Recombinant human factor D (expressed in E. coli and purified using standard methods) at 10 nM concentration is incubated with test compound at vario...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetComplement factor D(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 171334BDBM171334(US9085555, 764)
Affinity DataIC50: 4nMpH: 7.5 T: 2°CAssay Description:Recombinant human factor D (expressed in E. coli and purified using standard methods) at 10 nM concentration is incubated with test compound at vario...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetComplement factor D(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 171314BDBM171314(US9085555, 744)
Affinity DataIC50: 4nMpH: 7.5 T: 2°CAssay Description:Recombinant human factor D (expressed in E. coli and purified using standard methods) at 10 nM concentration is incubated with test compound at vario...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetComplement factor D(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 171324BDBM171324(US9085555, 754)
Affinity DataIC50: 5nMpH: 7.5 T: 2°CAssay Description:Recombinant human factor D (expressed in E. coli and purified using standard methods) at 10 nM concentration is incubated with test compound at vario...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetComplement factor D(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 170734BDBM170734(US9085555, 162)
Affinity DataIC50: 5nMpH: 7.5 T: 2°CAssay Description:Recombinant human factor D (expressed in E. coli and purified using standard methods) at 10 nM concentration is incubated with test compound at vario...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetComplement factor D(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 171255BDBM171255(US9085555, 685)
Affinity DataIC50: 5nMpH: 7.5 T: 2°CAssay Description:Recombinant human factor D (expressed in E. coli and purified using standard methods) at 10 nM concentration is incubated with test compound at vario...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetComplement factor D(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 171208BDBM171208(US9085555, 638)
Affinity DataIC50: 5nMpH: 7.5 T: 2°CAssay Description:Recombinant human factor D (expressed in E. coli and purified using standard methods) at 10 nM concentration is incubated with test compound at vario...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetComplement factor D(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 171315BDBM171315(US9085555, 745)
Affinity DataIC50: 5nMpH: 7.5 T: 2°CAssay Description:Recombinant human factor D (expressed in E. coli and purified using standard methods) at 10 nM concentration is incubated with test compound at vario...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetComplement factor D(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 171332BDBM171332(US9085555, 762)
Affinity DataIC50: 5nMpH: 7.5 T: 2°CAssay Description:Recombinant human factor D (expressed in E. coli and purified using standard methods) at 10 nM concentration is incubated with test compound at vario...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetComplement factor D(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 170934BDBM170934(US9085555, 362)
Affinity DataIC50: 5nMpH: 7.5 T: 2°CAssay Description:Recombinant human factor D (expressed in E. coli and purified using standard methods) at 10 nM concentration is incubated with test compound at vario...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetComplement factor D(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 170949BDBM170949(US9085555, 379)
Affinity DataIC50: 5nMpH: 7.5 T: 2°CAssay Description:Recombinant human factor D (expressed in E. coli and purified using standard methods) at 10 nM concentration is incubated with test compound at vario...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetComplement factor D(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 171311BDBM171311(US9085555, 757 | US9085555, 741)
Affinity DataIC50: 5nMpH: 7.5 T: 2°CAssay Description:Recombinant human factor D (expressed in E. coli and purified using standard methods) at 10 nM concentration is incubated with test compound at vario...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetComplement factor D(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 170866BDBM170866(US9085555, 294)
Affinity DataIC50: 5nMpH: 7.5 T: 2°CAssay Description:Recombinant human factor D (expressed in E. coli and purified using standard methods) at 10 nM concentration is incubated with test compound at vario...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetComplement factor D(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 171313BDBM171313(US9085555, 743)
Affinity DataIC50: 5nMpH: 7.5 T: 2°CAssay Description:Recombinant human factor D (expressed in E. coli and purified using standard methods) at 10 nM concentration is incubated with test compound at vario...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetComplement factor D(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 170750BDBM170750(US9085555, 178)
Affinity DataIC50: 6nMpH: 7.5 T: 2°CAssay Description:Recombinant human factor D (expressed in E. coli and purified using standard methods) at 10 nM concentration is incubated with test compound at vario...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetComplement factor D(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 171236BDBM171236(US9085555, 666)
Affinity DataIC50: 6nMpH: 7.5 T: 2°CAssay Description:Recombinant human factor D (expressed in E. coli and purified using standard methods) at 10 nM concentration is incubated with test compound at vario...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetComplement factor D(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 170775BDBM170775(US9085555, 203)
Affinity DataIC50: 6nMpH: 7.5 T: 2°CAssay Description:Recombinant human factor D (expressed in E. coli and purified using standard methods) at 10 nM concentration is incubated with test compound at vario...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetComplement factor D(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 171270BDBM171270(US9085555, 700)
Affinity DataIC50: 6nMpH: 7.5 T: 2°CAssay Description:Recombinant human factor D (expressed in E. coli and purified using standard methods) at 10 nM concentration is incubated with test compound at vario...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetComplement factor D(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 171263BDBM171263(US9085555, 693)
Affinity DataIC50: 6nMpH: 7.5 T: 2°CAssay Description:Recombinant human factor D (expressed in E. coli and purified using standard methods) at 10 nM concentration is incubated with test compound at vario...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetComplement factor D(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 170705BDBM170705(US9085555, 133)
Affinity DataIC50: 6nMpH: 7.5 T: 2°CAssay Description:Recombinant human factor D (expressed in E. coli and purified using standard methods) at 10 nM concentration is incubated with test compound at vario...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetComplement factor D(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 170892BDBM170892(US9085555, 320)
Affinity DataIC50: 7nMpH: 7.5 T: 2°CAssay Description:Recombinant human factor D (expressed in E. coli and purified using standard methods) at 10 nM concentration is incubated with test compound at vario...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetComplement factor D(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 171002BDBM171002(US9085555, 432)
Affinity DataIC50: 7nMpH: 7.5 T: 2°CAssay Description:Recombinant human factor D (expressed in E. coli and purified using standard methods) at 10 nM concentration is incubated with test compound at vario...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetComplement factor D(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 170955BDBM170955(US9085555, 385)
Affinity DataIC50: 7nMpH: 7.5 T: 2°CAssay Description:Recombinant human factor D (expressed in E. coli and purified using standard methods) at 10 nM concentration is incubated with test compound at vario...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetComplement factor D(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 171326BDBM171326(US9085555, 756)
Affinity DataIC50: 7nMpH: 7.5 T: 2°CAssay Description:Recombinant human factor D (expressed in E. coli and purified using standard methods) at 10 nM concentration is incubated with test compound at vario...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetComplement factor D(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 171342BDBM171342(US9085555, 772)
Affinity DataIC50: 7nMpH: 7.5 T: 2°CAssay Description:Recombinant human factor D (expressed in E. coli and purified using standard methods) at 10 nM concentration is incubated with test compound at vario...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetComplement factor D(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 170776BDBM170776(US9085555, 204)
Affinity DataIC50: 7nMpH: 7.5 T: 2°CAssay Description:Recombinant human factor D (expressed in E. coli and purified using standard methods) at 10 nM concentration is incubated with test compound at vario...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetComplement factor D(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 170586BDBM170586(US9085555, 11)
Affinity DataIC50: 7nMpH: 7.5 T: 2°CAssay Description:Recombinant human factor D (expressed in E. coli and purified using standard methods) at 10 nM concentration is incubated with test compound at vario...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetComplement factor D(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 170962BDBM170962(US9085555, 392)
Affinity DataIC50: 7nMpH: 7.5 T: 2°CAssay Description:Recombinant human factor D (expressed in E. coli and purified using standard methods) at 10 nM concentration is incubated with test compound at vario...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetComplement factor D(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 170963BDBM170963(US9085555, 393)
Affinity DataIC50: 7nMpH: 7.5 T: 2°CAssay Description:Recombinant human factor D (expressed in E. coli and purified using standard methods) at 10 nM concentration is incubated with test compound at vario...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetComplement factor D(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 171316BDBM171316(US9085555, 746)
Affinity DataIC50: 7nMpH: 7.5 T: 2°CAssay Description:Recombinant human factor D (expressed in E. coli and purified using standard methods) at 10 nM concentration is incubated with test compound at vario...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetComplement factor D(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 170870BDBM170870(US9085555, 298)
Affinity DataIC50: 7nMpH: 7.5 T: 2°CAssay Description:Recombinant human factor D (expressed in E. coli and purified using standard methods) at 10 nM concentration is incubated with test compound at vario...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetComplement factor D(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 170576BDBM170576(US9085555, 1)
Affinity DataIC50: 7nMpH: 7.5 T: 2°CAssay Description:Recombinant human factor D (expressed in E. coli and purified using standard methods) at 10 nM concentration is incubated with test compound at vario...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

Displayed 1 to 50 (of 773 total ) | Next | Last >>
Jump to: